Proteomic approaches to characterize protein modifications: New tools to study the effects of environmental exposures

Environmental Health Perspectives

Volumn 110, Issue SUPPL. 1, 2002, Pages 3-9

  Liebler, Daniel C ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Functional genomics; Mass spectrometry; Protein adducts; Proteomics; Stress responses

Indexed keywords

BIOLOGICAL MARKER; CHEMICAL AGENT; PROTEOME;

ALGORITHM; AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DATA BASE; DEVICE; ENVIRONMENTAL EXPOSURE; GENE SEQUENCE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN TARGETING; PROTEOMICS; SAMPLE; STIMULUS; STRESS;

EID: 0036182039     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.02110s113     Document Type: Article

References (66)

1. The sequence of the human genome
2. Initial sequencing and analysis of the human genome
3. Mass spectrometry and the age of the proteome
4. Proteomics to study genes and genomes
5. Identifying the proteome: Software tools
6. Comparative genomics of the eukaryotes
7. MALDI guadrupole time-of-flight mass spectrometry: A powerful tool for proteomic research
8. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database
9. High throughput protein characterization by automated reverse-phase chromatography/electrospray tandem mass spectrometry
10. Direct analysis of protein complexes using mass spectrometry
11. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules
12. Acetaminophen-induced hepatic necrosis. II: Role of covalent binding in vivo
13. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite
14. Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro
15. Acetaminophen-induced hepatic necrosis. V: Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters
16. Comparative cytotoxic effects of acetaminophen (N-acetyl-p-aminophenol), a non-hepatotoxic regioisomer acetyl-m-aminophenol and their postulated reactive hydroquinone and quinone metabolites in monolayer cultures of mouse hepatocytes
17. Hepatic protein arylation, glutathione depletion, and metabolite profiles of acetaminophen and a non-hepatotoxic regioisomer, 3′-hydroxyacetanilide, in the mouse
18. Multiple reactive metabolites derived from bromobenzene
19. Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals
20. Selective protein covalent binding and target organ toxicity
21. Role of covalent and noncovalent interactions in cell toxicity: Effects on proteins
22. Covalent binding of xenobiotics to specific proteins in the liver
23. Enzymatic activation of chemicals to toxic metabolites
24. Immunological studies on the mechanism of halothane-induced hepatotoxicity: Immunohistochemical evidence of trifluoroacetylated hepatocytes
25. Detection of benzoquinone adducts to rat liver protein sulfhydryl groups using specific antibodies
26. Covalent modification of rat liver dipeptidyl dipeptidase IV (CD 26) by the nonsteroidal anti-inflammatory drug diclofenac
27. Mitochondrial HSP60 (P1 protein) and a HSP70-like protein (mortalin) are major targets for modification during S-(1,1,2,2-tetrafluoroethyl)-L-cysteine-induced nephrotoxicity
28. A comparative study of mouse liver proteins arylated by reactive metabolites of acetaminophen and its nonhepatotoxic regioisomer, 3′-hydroxyacetanilide
29. S-(2-Chloroacetyl)-glutathione, a reactive glutathione thiolester and a putative metabolite of 1,1-dichloroethylene
30. Carbamoylation of peptides and proteins in vitro by S-(N-methylcarbamoyl)glutathione and S-(N-methylcarbamoyl)cysteine, two electrophilic S-linked conjugates of methyl isocyanate
31. Alkylation of oxytocin by S-(2-chloroethyl) glutathione and characterization of adducts by tandem mass spectrometry and Edman degradation
32. Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin. Studies by tandem mass spectrometry
33. Synthesis and mass-spectrometric characterization of human serum albumins modified by covalent binding of two non-steroidal anti-inflammatory drugs: Tolmetin and zomepirac
34. Reactivity of tolmetin glucuronide with human serum albumin. Identification of binding sites and mechanisms of reaction by tandem mass spectrometry
35. Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry
36. Characterization of structural xenobiotic modifications in proteins by high sensitivity tandem mass spectrometry. Human hemoglobin treated in vitro with styrene 7,8-oxide
37. First direct evidence for lipid/protein conjugation in oxidized human low density lipoprotein
38. Alkylation of Escherichia coli thioredoxin by S-(2-chloroethyl)glutathione and identification of the adduct on the active site cysteine-32 by mass spectrometry
39. Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry
40. SALSA: A pattern recognition algorithm to detect electrophile-adducted peptides by automated evaluation of CID spectra in LC-MS-MS analyses
41. Characterization of benzoquinone-peptide adducts by electrospray mass spectrometry
42. Tandem MS analysis of model peptide adducts from reactive metabolites of the hepatotoxin 1,1-dichloroethylene
43. Detection and identification of carcinogen-peptide adducts by nanoelectrospray tandem mass spectrometry
44. Peptide sequence motif analysis of tandem MS data with the SALSA algorithm
45. Large-scale analysis of the yeast proteome by multidimensional protein identification technology
46. Studies using specific biomarkers for human exposure assessment to exogenous and endogenous chemical agents
47. Protein adducts as biomarkers of human carcinogen exposure
48. Protein adducts in the molecular dosimetry of chemical carcinogens
49. The role of metabolic activation in drug toxicity
50. Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun NH{sub2} terminal kinase (JNK1) signaling through interaction with the carboxyl terminus
51. 2-induced cell death via coordinated regulation of stress kinases
52. 2-induced cell death
53. Regulation of JNK signaling by GSTp
54. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1
55. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1
56. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain
57. Distinct endoplasmic reticulum signaling pathways regulate apoptotic and necrotic cell death following iodoacetamide treatment
58. 2+ disturbances, and cell death in renal epithelial cells
59. Signalling the molecular stress response to nephrotoxic and mutagenic cysteine conjugates: Differential roles for protein synthesis and calcium in the induction of c-fos and c-myc mRNA in LLC-PK1 cells
60. Stress signaling from the lumen of the endoplasmic reticulum: Coordination of gene transcriptional and translational controls
61. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002
62. Identification of phosphorylation sites of human 85-kDa cytosolic phospholipase A2 expressed in insect cells and present in human monocytes
63. Immobilized gallium(III) affinity chromatography of phosphopeptides
64. Site-selective nitration of tyrosine in human serum albumin by peroxynitrite
65. Identification of the protein-drug adduct formed between aldehyde dehydrogenase and S-methyl-N,N-diethylthiocarbamoyl sulfoxide by on-line proteolytic digestion high performance liquid chromatography electrospray spectrometry